Global Diabetes Management Devices Market 2017-2021

糖尿病管理デバイスの世界市場2017-2021

◆タイトル:Global Diabetes Management Devices Market 2017-2021
◆商品コード:IRTNTR15766
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年11月16日
◆ページ数:122
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥388,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、糖尿病管理デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、糖尿病管理デバイスの世界市場規模及び予測、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。Technavio社は糖尿病管理デバイスの世界市場が2017-2021年期間中に年平均8.08%成長すると予測しています。当レポート上に記載されている主な企業は、Abbott、Dexcom、F. Hoffmann-La Roche、LifeScan、Medtronic等です。

About Diabetes Management Devices
Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.
Technavio’s analysts forecast the global diabetes management devices market to grow at a CAGR of 8.08% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global diabetes management devices market for 2017-2021. To calculate the market size, the report considers the sales from insulin delivery systems and continuous blood glucose monitoring systems.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Diabetes Management Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott
• Dexcom
• F. Hoffmann-La Roche
• LifeScan
• Medtronic

[Other prominent vendors]
• AgaMatrix
• Animas
• ARKRAY
• Ascensia Diabetes Care
• B. Braun Melsungen
• BD
• Beta Bionics
• Bigfoot Biomedical
• BIONIME USA
• CellNovo
• Eli Lilly
• iHealth Labs
• Insulet
• Nemaura Medical
• Nipro
• Nova Biomedical
• Novo Nordisk
• Panasonic Healthcare
• Prodigy Diabetes Care
• Sanofi
• Senseonics
• Tandem Diabetes Care
• Trividia Health
• TypeZero Technologies
• Valeritas
• WellDoc

[Market driver]
• Rising global burden of diabetes
• For a full, detailed list, view our report

[Market challenge]
• Prohibitive cost of the diabetes care devices
• For a full, detailed list, view our report

[Market trend]
• Growing focus on artificial pancreas
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Market outline

PART 05: MARKET LANDSCAPE
• Market overview
• Five forces analysis

PART 06: MARKET SEGMENTATION BY PRODUCT
• Comparison by product
• Insulin delivery systems
• Blood glucose monitoring devices
• Market opportunity by product

PART 07: MARKET SEGMENTATION BY END-USERS
• Hospitals
• Specialty diabetes clinics
• Home care settings
• Others

PART 08: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Diabetes management devices market in Americas
• Diabetes management devices market in EMEA
• Diabetes management devices market in APAC
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 11: MARKET TRENDS
• Growing focus on artificial pancreas
• Increasing focus on home care settings
• Technological advancements/improvements

PART 12: VENDOR LANDSCAPE
• Competitive scenario
• Key news
• M&A

PART 13: VENDOR ANALYSIS
• Vendor overview
• Abbott
• Dexcom
• F. Hoffmann-La Roche
• LifeScan
• Medtronic
• Other prominent vendors

PART 14: APPENDIX0
• List of abbreviations0

[List of Exhibits]
Exhibit 01: Types of diabetes
Exhibit 02: Risk factors for diabetes
Exhibit 03: Global diabetes management devices market 2016-2021 ($ millions)
Exhibit 04: Five forces
Exhibit 05: Segmentation of global diabetes management devices by product 2016
Exhibit 06: Global diabetes management devices market analysis by product 2016
Exhibit 07: Global diabetes management devices market by product 2016 and 2021 (%)
Exhibit 08: Global diabetes management devices market by product 2016 and 2021 ($ millions)
Exhibit 09: Global diabetes management devices market share by product 2016-2021 (%)
Exhibit 10: Comparison by product
Exhibit 11: Global insulin delivery systems market 2016-2021 ($ millions)
Exhibit 12: Global insulin delivery systems market: Year-over-year (YoY) growth 2017-2021 (%)
Exhibit 13: Global blood glucose monitoring devices market 2016-2021 ($ millions)
Exhibit 14: Global blood glucose monitoring devices market: YoY growth 2017-2021 (%)
Exhibit 15: Global diabetes management devices market: Opportunity by product
Exhibit 16: Global diabetes management devices market by end-users 2016 (%)
Exhibit 17: Global diabetes management devices market analysis by geography 2016
Exhibit 18: Segmentation of global diabetes management devices market by geography 2016 and 2021 ($ millions)
Exhibit 19: Segmentation of global diabetes management devices market by geography 2016 and 2021 (%)
Exhibit 20: Global diabetes management devices market share by geography 2016-2021 (%)
Exhibit 21: Global diabetes management devices market: Regional comparison
Exhibit 22: Diabetes management devices market in Americas 2016-2021 ($ millions)
Exhibit 23: Diabetes management devices market in Americas: YoY growth 2017-2021 (%)
Exhibit 24: Top three countries in Americas
Exhibit 25: Diabetes management devices market in EMEA 2016-2021 ($ millions)
Exhibit 26: Diabetes management devices market in EMEA: YoY growth 2017-2021 (%)
Exhibit 27: Top three countries in EMEA
Exhibit 28: Diabetes management devices market in APAC 2016-2021 ($ millions)
Exhibit 29: Diabetes management devices market in APAC: YoY growth 2017-2021 (%)
Exhibit 30: Top three countries in APAC
Exhibit 31: Prevalence of diabetes 2000 and 2030 (millions)
Exhibit 32: Recent product launches
Exhibit 33: Product recalls
Exhibit 34: Pipeline products
Exhibit 35: Abbott: Key highlights
Exhibit 36: Abbott: Strength assessment
Exhibit 37: Abbott: Strategy assessment
Exhibit 38: Abbott: Opportunity assessment
Exhibit 39: Dexcom: Key highlights
Exhibit 40: Dexcom: Strength assessment
Exhibit 41: Dexcom: Strategy assessment
Exhibit 42: Dexcom: Opportunity assessment
Exhibit 43: F. Hoffmann-La Roche: Key highlights
Exhibit 44: F. Hoffmann-La Roche: Strength assessment
Exhibit 45: F. Hoffmann-La Roche: Strategy assessment
Exhibit 46: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 47: LifeScan: Key highlights
Exhibit 48: LifeScan: Strength assessment
Exhibit 49: LifeScan: Strategy assessment
Exhibit 50: LifeScan: Opportunity assessment
Exhibit 51: Medtronic: Key highlights
Exhibit 52: Medtronic: Strength assessment
Exhibit 53: Medtronic: Strategy assessment
Exhibit 54: Medtronic: Opportunity assessment



【掲載企業】

Abbott, Dexcom, F. Hoffmann-La Roche, LifeScan, Medtronic, AgaMatrix, Animas, ARKRAY, Ascensia Diabetes Care, B. Braun Melsungen, BD, Beta Bionics, Bigfoot Biomedical, BIONIME USA, CellNovo, Eli Lilly, iHealth Labs, Insulet, Nemaura Medical, Nipro, Nova Biomedical, Novo Nordisk, Panasonic Healthcare, Prodigy Diabetes Care, Sanofi, Senseonics, Tandem Diabetes Care, Trividia Health, TypeZero Technologies, Valeritas, and WellDoc.


【資料のキーワード】

糖尿病管理デバイス、医療機器

★調査レポート[糖尿病管理デバイスの世界市場2017-2021] (Global Diabetes Management Devices Market 2017-2021 / IRTNTR15766)販売に関する免責事項
[糖尿病管理デバイスの世界市場2017-2021] (Global Diabetes Management Devices Market 2017-2021 / IRTNTR15766)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆